2026-03-20 • tradersunion.com
Novo Nordisk shares decline 3.23% following a clinical trial failure
2026-03-20 • tradersunion.com
Novo Nordisk shares decline 3.23% following a clinical trial failure2026-03-20 • PR Newswire
The FDA authorized Novo Nordisk’s Wegovy® HD injection, offering the greatest weight loss achieved with Wegovy® to date and expanding the drug’s existing clinical data.2026-03-14 • ng.investing.com
Novo Nordisk provides Prothena with a 50 million dollar milestone regarding a drug trial2026-03-12 • PR Newswire
Pomerantz Law Firm Files Investor Suits Against Novo Nordisk A/S - NVO2026-03-11 • in.investing.com
Novo Nordisk provides Prothena with a 50 million dollar milestone regarding a drug trial2026-03-11 • prnewswire.co.uk
WHO Foundation and Novo Nordisk are broadening their partnership to offer funding aimed at bolstering healthcare systems addressing Cardio-Renal-Metabolic Diseases.2026-03-11 • biospace.com
Prothena Received $50 Million Payment from Novo Nordisk for Coramitug Phase 3 Trial Progress in Cardiomyopathy ATTR Amyloidosis2026-03-11 • PR Newswire
WHO Foundation and Novo Nordisk Jointly Partner to Aid Childhood Obesity Fight in India2026-03-06 • medwatch.com
Novo Nordisk is conducting a Phase 1 trial for a novel weight-loss medication.2026-03-02 • PR Newswire
Novo Nordisk’s Sogroya® receives FDA approval as the initial and sole weekly, extended-release growth hormone for three more pediatric uses2026-02-28 • drugdiscoverytrends.com
Triple agonist from Novo Nordisk achieves up to 19.7% average weight loss during Phase 2 trial.2026-02-26 • biopharmadive.com
Novo seeks a breakthrough as it highlights fresh data on a three-drug obesity treatment.2026-02-26 • clinicaltrialsarena.com
Novo Nordisk’s partner drug achieved 19.7% weight loss during Phase II testing.2026-02-25 • m.uk.investing.com
Novo Nordisk Stock Rating Cut by JPMorgan Due to Clinical Trial Results2026-02-25 • devdiscourse.com
Novo Nordisk and United Laboratories' "triple G" drug trial yields 19.7% weight loss results.2026-02-25 • investorsobserver.com
Novo Nordisk Stock Drops Sharply Following Obesity Trial Disappointment2026-02-25 • meyka.com
Novo Nordisk and United Biotechnology Reveal 19.7% Weight Loss Results in Recent Study2026-02-25 • in.investing.com
Novo Nordisk Stock Rating Cut by JPMorgan Due to Clinical Trial Results2026-02-25 • azat.tv
Novo Nordisk Shares Decline Following Negative CagriSema Trial Outcomes2026-02-24 • statnews.com
Novo Nordisk’s new obesity drug shows disappointing results in latest trial.2026-02-24 • manilatimes.net
Novo Nordisk’s UBT251, a triple agonist, showed up to 19.7% average weight loss over 24 weeks during a Phase 2 trial in China.2026-02-24 • bitget.com
Eli Lilly’s weight loss drug outperformed Novo Nordisk’s in a key trial, causing Novo Nordisk’s stock to drop 13.8% before market open.2026-02-24 • gurufocus.com
Novo Nordisk (NVO) Experiences Difficulty in Obesity Drug Trial2026-02-24 • m.in.investing.com
Novo Nordisk’s obesity drug failed to meet trial goals, boosting Eli Lilly’s stock price.2026-02-24 • forbes.com
Eli Lilly’s Weight Loss Shot Outperforms Novo Nordisk’s in Clinical Trial—Novo Nordisk Stock Drops Sharply2026-02-24 • clinicaltrialsarena.com
Zepbound outperformed Novo Nordisk’s CagriSema in a recent head-to-head clinical trial.1 hour ago • prnewswire.co.uk
Pocket Broker Secures the Winter 2026 Top Performer Award from SourceForge1 hour ago • prnewswire.co.uk
The Consulting Firm Behind How The World's Wealthiest Clients Are Treated Just Had A Record Year3 hours ago • prnewswire.co.uk
Digital Dentistry Market to Reach US$ 13.7 Billion by 2033 Expands Amid Rapid Technological Adoption and Precision Care Demand - Persistence Market Research3 hours ago • prnewswire.co.uk
A Success Story - DelveInsight's Strategic Support to a Pharma Company in Interleukin-2 Target Patient Pool and Epidemiology-based Market Forecast Analysis4 hours ago • prnewswire.co.uk
NYSE Announces: The Hill and Valley Forum Hosts Executives in Washington5 hours ago • prnewswire.co.uk
Athena Intelligence Announces India Expansion Facing Increased Border Corporate Threats7 hours ago • prnewswire.co.uk
Bybit Trading Bots Now Available for Stocks, Increasing Automated Trading of Tokenized Securities19 hours ago • prnewswire.co.uk
Paratus Energy Services Ltd. Reports Sale of Jack-up Operations20 hours ago • prnewswire.co.uk
Food Testing Market Forecasts USD 29.43 Billion Reach by 2032 Due to Increasing Food Safety Worries, Says MarkNtel Advisors2026-03-23 • kbc.co.ke
Nairobi Eastland’s water crisis addressed by a Ksh 1.4 billion project2026-03-23 • mining.com.au
Canada provided funding for Scandium to create unique aluminium-scandium alloys2026-03-23 • livemint.com
Steel tariff protection could boost Tata Steel UK’s operations—yet it is unlikely to happen before the fiscal year ending 2027.12 minutes ago • EIN Presswire
Ikon Technologies Names Michael Wymard President to Lead AI-Driven Expansion in Automotive Retail12 minutes ago • EIN Presswire
Reuben Raucher & Blum’s Stephen Raucher Recognized for Leadership in Insurance Coverage and Litigation12 minutes ago • EIN Presswire
ITS Expands Cybersecurity Capabilities with Black Breach Acquisition, Launches Dedicated Cybersecurity Team4 hours ago • PR Newswire
Cipla Health Expands ProlyteORS Range Featuring Masala Guava Taste7 hours ago • PR Newswire
Protean Digital Disruptors 2026 honors innovators driving India’s future financial system9 hours ago • PR Newswire
The Protean 'Digital Disruptors 2026' award recognizes innovative leaders transforming India’s financial sector.57 minutes ago • EIN Presswire
tigerlab Launches AI-Native Broker Management System Across 30+ Countries2 hours ago • EIN Presswire
BlueKong Networks unveils BlueKong Go — an On-Demand Platform set to transform IT Field Services.2 hours ago • EIN Presswire
Gold Prices Show Limited Movement as Tokenised Access Continues to GrowStay ahead with real-time headlines from top sources, categorized by sector and country.